The Claim
Differentiated orbital fibroblasts from patients with severe Graves' ophthalmopathy express higher levels of thyrotropin receptor mRNA than nondifferentiated orbital fibroblasts from the same patients.
What the research says
Supports is higher
Support is ahead, but a single strong opposing study can change this.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
In patients with severe Graves' ophthalmopathy, orbital fibroblasts that have matured into a specialized state show higher levels of thyrotropin receptor mRNA than those that have not matured.
See the scientific wording
Differentiated orbital fibroblasts from patients with severe Graves' ophthalmopathy express higher levels of thyrotropin receptor mRNA compared to their nondifferentiated counterparts.
When fat cells in the eye become mature, they turn on more of the gene that makes the thyrotropin receptor. This allows them to respond more strongly to antibodies that mistakenly target this receptor, triggering tissue swelling.
What the research says
1 studyIn people with severe Graves' eye disease, the matured eye fat cells have more of the TSH receptor gene active than the immature ones—this study proved it by measuring the gene activity directly.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.